120 related articles for article (PubMed ID: 22956556)
1. Seizures and type 1 diabetes mellitus: current state of knowledge.
Verrotti A; Scaparrotta A; Olivieri C; Chiarelli F
Eur J Endocrinol; 2012 Dec; 167(6):749-58. PubMed ID: 22956556
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic seizures and epilepsy in type I diabetes mellitus.
Falip M; Miró J; Carreño M; Jaraba S; Becerra JL; Cayuela N; Perez Maraver M; Graus F
J Neurol Sci; 2014 Nov; 346(1-2):307-9. PubMed ID: 25183236
[TBL] [Abstract][Full Text] [Related]
3. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
[TBL] [Abstract][Full Text] [Related]
4. Systemic and neurologic autoimmune disorders associated with seizures or epilepsy.
Vincent A; Crino PB
Epilepsia; 2011 May; 52 Suppl 3():12-7. PubMed ID: 21542840
[TBL] [Abstract][Full Text] [Related]
5. Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.
Lilleker JB; Biswas V; Mohanraj R
Seizure; 2014 Sep; 23(8):598-602. PubMed ID: 24836709
[TBL] [Abstract][Full Text] [Related]
6. GAD-65 autoantibody associated epilepsy.
Dimova R; Grozeva G; Chakarova N; Tsarkova P; Tankova T
J Pediatr Endocrinol Metab; 2020 May; 33(6):817-820. PubMed ID: 32436860
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
8. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
9. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
Tsirogianni A; Pipi E; Soufleros K
Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
[No Abstract] [Full Text] [Related]
11. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies.
Vianello M; Keir G; Giometto B; Betterle C; Tavolato B; Thompson EJ
Eur J Neurol; 2005 Apr; 12(4):294-9. PubMed ID: 15804247
[TBL] [Abstract][Full Text] [Related]
12. Electroencephalographic abnormalities in children with type 1 diabetes mellitus: a prospective study.
Yildirim R; Günbey C
Turk J Med Sci; 2023; 53(6):1794-1798. PubMed ID: 38813513
[TBL] [Abstract][Full Text] [Related]
13. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
14. Investigation of enterovirus infections, autoimmune factors and HLA genotypes in patients with T1DM.
Çekin Y; Özkaya E; Gülkesen H; Akçurin S; Çolak D
Minerva Endocrinol; 2014 Mar; 39(1):67-74. PubMed ID: 24513606
[TBL] [Abstract][Full Text] [Related]
15. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
[TBL] [Abstract][Full Text] [Related]
16. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives.
Dagdelen S; Hascelik G; Bayraktar M
Int J Clin Pract; 2009 Mar; 63(3):449-56. PubMed ID: 18218004
[TBL] [Abstract][Full Text] [Related]
19. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM).
Karavanaki K; Kakleas K; Paschali E; Kefalas N; Konstantopoulos I; Petrou V; Kanariou M; Karayianni C
Horm Res; 2009; 71(4):201-6. PubMed ID: 19258711
[TBL] [Abstract][Full Text] [Related]
20. Serum antibodies in epilepsy and seizure-associated disorders.
McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]